Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; …
Over the last 12 months, insiders at Zynex, Inc. have bought $58,233 and sold $698,990 worth of Zynex, Inc. stock.
On average, over the past 5 years, insiders at Zynex, Inc. have bought $53,864 and sold $14.01M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Disbrow Joshua R. (director) — $116,466.
The last purchase of 7,000 shares for transaction amount of $58,233 was made by Disbrow Joshua R. (director) on 2024‑07‑29.
2024-12-02 | Sale | CHIEF FINANCIAL OFFICER | 10,000 0.0308% | $8.08 | $80,800 | -0.73% | ||
2024-11-14 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0064% | $8.09 | $16,180 | 0.00% | ||
2024-11-13 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0065% | $8.37 | $16,740 | +0.92% | ||
2024-11-12 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0068% | $9.24 | $18,480 | -4.43% | ||
2024-11-11 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0062% | $9.09 | $18,180 | -11.77% | ||
2024-11-08 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0061% | $8.77 | $17,540 | -8.77% | ||
2024-11-07 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0065% | $9.17 | $18,340 | -6.91% | ||
2024-11-06 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0061% | $8.82 | $17,640 | -10.75% | ||
2024-11-05 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0063% | $8.05 | $16,100 | 0.00% | ||
2024-11-04 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0068% | $8.67 | $17,340 | +2.94% | ||
2024-11-01 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0062% | $8.63 | $17,260 | -6.16% | ||
2024-11-01 | Sale | CHIEF FINANCIAL OFFICER | 10,000 0.0308% | $8.59 | $85,900 | -6.16% | ||
2024-10-31 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0064% | $8.82 | $17,640 | -4.58% | ||
2024-10-30 | Sale | PRESIDENT, CEO AND CHAIRMAN | 2,000 0.0062% | $8.92 | $17,840 | -8.54% | ||
2024-08-07 | Sale | CHIEF OPERATING OFFICER | 8,083 0.0255% | $8.03 | $64,906 | +0.75% | ||
2024-08-06 | Sale | CHIEF OPERATING OFFICER | 16,792 0.0532% | $8.01 | $134,504 | +1.13% | ||
2024-07-30 | Sale | CHIEF FINANCIAL OFFICER | 15,000 0.0474% | $8.24 | $123,600 | +1.33% | ||
2024-07-29 | director | 7,000 0.022% | $8.32 | $58,233 | -3.36% | |||
2023-08-04 | Sale | Chief Financial Officer | 20,000 0.056% | $8.49 | $169,800 | +20.77% | ||
2023-08-04 | Sale | Chief Operating Officer | 12,000 0.0333% | $8.41 | $100,920 | +20.77% |
Sandgaard Thomas | PRESIDENT, CEO AND CHAIRMAN | 14603662 45.8579% | $8.28 | 21 | 50 | |
Disbrow Joshua R. | director | 72000 0.2261% | $8.28 | 1 | 0 | |
MOORHEAD DANIEL J | CHIEF FINANCIAL OFFICER | 35190 0.1105% | $8.28 | 2 | 14 | +30.13% |
BlackRock | $16.51M | 4.2 | 1.33M | -7.92% | -$1.42M | <0.0001 | |
The Vanguard Group | $14.68M | 3.74 | 1.19M | +0.52% | +$75,419.89 | <0.0001 | |
Arrowstreet Capital, Limited Partnership | $7.11M | 1.81 | 574,887 | 0% | +$0 | 0.01 | |
Nantahala Capital Management Llc | $6.06M | 1.54 | 490,000 | +308.33% | +$4.58M | 0.28 | |
Hotchkis & Wiley Capital Management | $5.35M | 1.36 | 432,180 | New | +$5.35M | 0.02 |